An interventional study of Common Factors Group Psychotherapy in Major Depression, Generalized Anxiety and Stress Disorder, Post Traumatic, sponsored by University of Alabama at Birmingham. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-18.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.
2,741 studies on the registry are indexed under Depressive Disorder, Major; 559 are open to participants now.
Browse Depressive Disorder, Major studies →University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.
Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
We will use a general common factors psychotherapy utilizing only psychotherapeutic techniques common to most forms of psychotherapy (e.g., listening and communication skills)
Behavioral: Common Factors Group Psychotherapy
This intervention will not contain active ingredients from established specific forms of psychotherapy (e.g., cognitive-behavioral therapy, dialectical behavioral therapy)
Generalized Anxiety Disorder-7 Screener
Measure of anxiety symptoms. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
Patient Health Questionnaire-9 Screener
Measure of depressive symptoms. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
Patient Checklist-5
Measure of post-traumatic stress symptoms. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
Yale-Brown Obsessive Compulsive Scale
Measure of obsessive compulsive disorder symptoms. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
Alcohol Use Disorders Identification Test
Measure of concerning alcohol use. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test
Measure of substance use. High scores more use.
Time frame: At enrollment and at the end of treatment at 6 weeks
Life Quality Scale
Measure of life quality. High scores better life quality.
Time frame: At enrollment and at the end of treatment at 6 weeks
Experiential Avoidance Rating Scale
Measure of experiential avoidance. High scores more symptoms.
Time frame: At enrollment and at the end of treatment at 6 weeks
Therapeutic Alliance Scale
Measure of patient-therapist alliance during therapy. High scores better alliance.
Time frame: At conclusion of therapy after 6 weeks.
No study locations are listed for this record.
Plan to share: Yes — All de-identified data collected will be available2
No publications or documents are linked to this record.
This study is withdrawn, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham